CD59 and Duchenne muscular dystrophy: On the other hand, the circulating concentrations of two complement inhibitors, complement decay accelerating factor (DAF), and CD59 were found to be lower in GC-naïve DMD patients compared to controls and this could be associated with involvement of membrane attack complex (MAC) in DMD40.